Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
Ebiomedicine|February 4, 2018
A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic AccuracyE M Harding-Esch, E C Cousins, S-L C Chow, et al.
Bioorganic Chemistry|November 28, 2021
A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancerSvenja Lier, Andreas Sellmer, Felix Orben, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2022
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task forceShirley V Wang, Anton Pottegård, William Crown, et al.
EMBO Molecular Medicine|March 5, 2021
Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolismGoetz Hartleben, Kenji Schorpp, Yun Kwon, et al.
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
Clinical Pharmacology and Therapeutics|June 3, 2025
Optimizing Patient Registries for Regulatory Decision Making - Key Learnings From an HMA/EMA Multistakeholder WorkshopKelly Plueschke, Carla Jonker, Hanna Kankanen, et al.
JCI Insight|April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtypeFelix Orben, Katharina Lankes, Christian Schneeweis, et al.
Gut|November 26, 2025
Gut microbiota predict development of postdischarge diabetes mellitus in acute pancreatitisChristoph Ammer-Herrmenau, Richard Meier, Kai L Antweiler, et al.
Science (New York, N.Y.)|June 23, 1995
A single ataxia telangiectasia gene with a product similar to PI-3 kinaseK Savitsky, A Bar-Shira, S Gilad, et al.
British Journal of Clinical Pharmacology|March 13, 2020
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicinesJane Moseley, Spiros Vamvakas, Michael Berntgen, et al.
Pageof 23